Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma

EMBO Mol Med. 2020 Jan 9;12(1):e11749. doi: 10.15252/emmm.201911749.
No abstract available

Publication types

  • Published Erratum